Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 10, 2023 08:05 ET | Source: Palisade Bio, Inc.

Palisade Bio Reports Third Quarter 2023 Financial Results and Provides Business Outlook

– Transformational transaction jumpstarts development pipeline into high-value inflammatory bowel disease (IBD) market – Lead program, PALI-2108, oral prodrug therapy for the treatment...